TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04030273

Intervention type: DIAGNOSTIC_TEST
Intervention: Diagnostic hysteroscopy
Description: Diagnostic hysteroscopy performed in outpatient setting, using no touch vaginoscopy technique with a 2.9 mm 30-degree rigid hysteroscope with a single inflow sheet using normal saline as distention media.

Intervention type: DIAGNOSTIC_TEST
Intervention: Diagnostic hysteroscopy
Description: Diagnostic hysteroscopy performed in outpatient setting, using no touch vaginoscopy technique with a 2.9 mm 30-degree rigid hysteroscope with a single inflow sheet using normal saline as distention media.

Intervention type: DIAGNOSTIC_TEST
Intervention: Diagnostic hysteroscopy
Description: Diagnostic hysteroscopy performed in outpatient setting, using no touch vaginoscopy technique with a 2.9 mm 30-degree rigid hysteroscope with a single inflow sheet using normal saline as distention media.
Study: NCT05358769

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Incoxil food supplement and pelvic floor muscle exercise
Description: Incoxil supplement group receives standardized written and verbal instructions on how to perform PFME and are asked to perform the pelvic floor muscle exercises 3 times per day, with 15 repetitions per set, daily for 6 weeks. Women perform PFME at an intensity of at least 65-75% of one repetition maximum. (Repetition maximum load is the maximum weight or force an individual can exert in a single lift.) In addition participants receive Incoxil food supplement and take the supplement once a day.~Incoxil composition: creatine, l-leucine, zinc, calcium and magnesium. Incoxil is specifically designed to contain ingredients that help strengthen muscles during regular resistance training of moderate intensity.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Pelvic floor muscle exercise
Description: Group receives standardized written and verbal instructions on how to perform PFME and are asked to perform the pelvic floor muscle exercises 3 times per day, with 15 repetitions per set, daily for 6 weeks. Women perform PFME at an intensity of at least 65-75% of one repetition maximum. (Repetition maximum load is the maximum weight or force an individual can exert in a single lift.) In addition participants receive placebo food supplement to take once a day.
Study: NCT05770089

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Adapted Physical Activity (APA)
Description: A 8-weeks program of APA (2x1hour per week) via videoconferencing composed of resistance training and yoga.
Study: NCT05845424

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: High intensity statin plus ezetimibe therapy
Description: Rosuvastatin 20 mg + Ezetimibe 10 mg
Study: NCT04888312

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CD40 agonist mitazalimab in combination with chemotherapy
Description: Mitazalimab administered intravenously every 14 days in combination with standard of care chemotherapy modified FOLFIRINOX.
Study: NCT06771570

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Silver Nanoparticles Irrigation
Description: to evaluate the postoperative pain, antimicrobial efficiency, and periapical tissue healing following the use of silver nano particles solution as a final irrigation, using either conventional needle irrigation or XP-Endo Finisher activation, in necrotic mandibular molar teeth.
Study: NCT05666024

Intervention type: OTHER
Description: Prospective observational study
Study: NCT05569707

Intervention type: DEVICE
Group type: OTHER
Intervention: Magnetic sentinel lymph node biopsy by use of Magtrace®, in combination with SentiMag® and DiffMag
Description: In addition to the standard procedure, SLNs will be detected using two types of magnetometers (SentiMag® \& DiffMag) in combination with SPIO particles (Magtrace®).
Study: NCT05886348

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Model-A Novel spectacle lens
Description: Model-A Novel spectacle lenses will be given to 1 arm to wear for 36 months

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Model-B Novel spectacle lens
Description: Model-B Novel spectacle lenses will be given to 1 arm to wear for 36 months
Study: NCT04548245

Intervention type: DEVICE
Intervention: EEG
Description: EEG

Intervention type: DEVICE
Intervention: EEG
Description: EEG
Study: NCT04706338

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TMS treatment
Description: Using TMS to stimulate (5 Hz, 90%\~110% resting motor threshold) patients' primary motor area and SMA.
Study: NCT05859230

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Experimental: The probiotic drink study group
Description: The 100 ml volume of milk drink containing 10 billion Lacticaseibacillus paracasei strain Shirota is consumed once a day for 12-week intervention period, followed by a 6-week follow-up period. The intervention is double-blinded by study team members and subjects. The milk drink bottles are coded by the manufacturing company.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Comparator: The placebo drink study group
Description: The 100 ml volume of milk drink without containing Lacticaseibacillus paracasei strain Shirota is consumed once a day for 12-week intervention period, followed by a 6-week follow-up period. The intervention is double-blinded to study team members and subjects. The milk drink bottles are coded by the manufacturing company.
Study: NCT05886348

Intervention type: DEVICE
Group type: OTHER
Intervention: Single vision spectacle lens
Description: Single Vision Spectacle lenses will be given to 1 arm to wear for 36 months
Study: NCT04186741

Intervention type: DRUG
Intervention: Hyperbaric oxygen
Description: Patients already on treatment by hyperbaric oxygen therapy for medical conditions requiring treatment by it
Study: NCT06474559

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: LMA Protector
Description: LMA Protector will be inserted by a researcher after standard anesthesia induction. The view of the larynx will be assessed using fiberoptic grading scale.Mini bronchoalveolar lavage will be collected before the end of the procedure
Study: NCT06042517

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ultrasound
Description: The General Electric LOGIQ E10 ultrasound pulsed doppler imaging system and C1-6-D XDclear abdominal curvilinear probe will be used to administer ultrasound.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ultrasound
Description: The General Electric LOGIQ E10 ultrasound pulsed doppler imaging system and C1-6-D XDclear abdominal curvilinear probe will be used to administer ultrasound.
Study: NCT06178601

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RC48-ADC
Description: RC48-ADC （2.0 mg/kg，intravenous (IV) infusion，Q2W）, combined with cadonilimab（AK104）

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AK104
Description: AK104（6.0 mg/kg，intravenous (IV) infusion，Q2W）combined with RC48-ADC
Study: NCT04473469

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Medtronic Interstim II Model 3058 Neurostimulator
Description: Patients will undergo stimulation of the pudendal nerve. All stimulation parameters used will be within the normal hard-coded limits of the implantable pulse generator (IPG).
Study: NCT05828329

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Guided visualization of exams through immersive virtual reality
Description: During 4 weeks (twice per week), students will visualize a 30-minutes 360º video that simulates the experience of an exam, from first person perspective.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Guided visualization of exams through traditional method
Description: During 4 weeks (twice per week), students will listen a 30-minutes audio that explains the experience of an exam from first person.
Study: NCT06465407

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Collagen
Description: Participants will consume two 30-g amount of collagen peptides derived from bovine hide (commercially available as Vital Proteins or Peptan) mixed in 300 ml of orange gatorade zero.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Maltodextrin
Description: Participants will consume two 30-g amount of pure maltodextrin mixed in 300 ml of orange gatorade zero.
Study: NCT06474559

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Endotracheal tube
Description: tracheal intubation will be perform after standard anaesthetic induction. Cormack Lehane will be recorded. Mini bronchoalveolar lavage will be collected before the end of the procedure
Study: NCT05522348

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Stability of a two piece PSI deign in splintless maxillary orthognathic surgery
Description: two patient fitted custom made plates will be used for the fixation of the maxilla following le fort 1 osteotomy for the correction of the dentofacial deformity and the postoperative stability will be measured using postoperative xrays

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Stability of a one piece PSI deign in splintless maxillary orthognathic surgery
Description: one patient fitted custom made plate will be used for the fixation of the maxilla following le fort 1 osteotomy for the correction of the dentofacial deformity and the postoperative stability will be measured using postoperative xrays
Study: NCT05048095

Intervention type: OTHER
Intervention: AI cancer detection system
Description: The use of AI as a third reader and as a decision support system during consensus meeting
Study: NCT06145555

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Acute psychological sleep stabilization
Description: See above (arm description)

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Sleep hygiene education
Description: See above (arm description)
Study: NCT05296187

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: TEAS
Description: Transcutaneous electrical acupuncture stimulation

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: TEAS
Description: Transcutaneous electrical acupuncture stimulation
Study: NCT06771570

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Silver Nanoparticles Irrigation
Description: to evaluate the postoperative pain, antimicrobial efficiency, and periapical tissue healing following the use of silver nano particles solution as a final irrigation, using either conventional needle irrigation or XP-Endo Finisher activation, in necrotic mandibular molar teeth.

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Silver Nanoparticles Irrigation
Description: to evaluate the postoperative pain, antimicrobial efficiency, and periapical tissue healing following the use of silver nano particles solution as a final irrigation, using either conventional needle irrigation or XP-Endo Finisher activation, in necrotic mandibular molar teeth.
Study: NCT04737655

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: TRIMBOW® pressurised inhalation solution: Beclometasone dipropionate / formoterol fumarate /glycopyrronium 87/5/9 µg per inhalation
Description: Evaluate Trimbow associated with the standard of care in comparison with the standard of care alone.
Study: NCT05184608

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Cycling exercise
Description: 20 minutes of cycling (90 rpm).

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cycling exercise
Description: 20 minutes of cycling (90 rpm).

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cognitive tasks
Description: 20 minutes of cognitive tasks based on the different domains of the UPDRS scale.
Study: NCT05057169

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BNT162b2
Description: BNT162b2 is a nucleoside-modified mRNA encoding the trimerized SARS-CoV-2 spike glycoprotein. The vaccine is formulated in lipid nanoparticles that increase the efficiency of delivery of the mRNA into cells after intramuscular injection. BNT162b2 encodes the SARS- CoV-2 full-length spike, modified by two proline mutations to lock it in the prefusion conformation and more closely recreate the intact virus with which the elicited virus- neutralizing antibodies interact. mRNA vaccines use the pathogen's genetic code as the vaccine; hence they exploit the host cells to translate the code and generate the target spike protein. The protein then acts as an intracellular antigen to stimulate the immune response of the vaccinated individual. The mRNA is then degraded within days.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BNT162b2
Description: BNT162b2 is a nucleoside-modified mRNA encoding the trimerized SARS-CoV-2 spike glycoprotein. The vaccine is formulated in lipid nanoparticles that increase the efficiency of delivery of the mRNA into cells after intramuscular injection. BNT162b2 encodes the SARS- CoV-2 full-length spike, modified by two proline mutations to lock it in the prefusion conformation and more closely recreate the intact virus with which the elicited virus- neutralizing antibodies interact. mRNA vaccines use the pathogen's genetic code as the vaccine; hence they exploit the host cells to translate the code and generate the target spike protein. The protein then acts as an intracellular antigen to stimulate the immune response of the vaccinated individual. The mRNA is then degraded within days.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CoronaVac
Description: CoronaVac is a Vero cell-based, aluminium hydroxide-adjuvanted, β-propiolactone- inactivated vaccine based on the CZ02 strain. This strain of SARS-CoV-2 was isolated from the bronchoalveolar lavage of a hospitalized patient and is closely related to the 2019-nCoV- BetaCoV Wuhan/WIV04/2019 strain. Each 0.5 ml dose is composed of 3 μg of inactivated SARS-CoV-2 virus. The excipients are aluminium hydroxide, disodium hydrogen phosphate, sodium dihydrogen phosphate, sodium chloride, and water for injection.
Study: NCT06275945

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Voro Urologic Scaffold
Description: radical prostatectomy
Study: NCT05057169

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CoronaVac
Description: CoronaVac is a Vero cell-based, aluminium hydroxide-adjuvanted, β-propiolactone- inactivated vaccine based on the CZ02 strain. This strain of SARS-CoV-2 was isolated from the bronchoalveolar lavage of a hospitalized patient and is closely related to the 2019-nCoV- BetaCoV Wuhan/WIV04/2019 strain. Each 0.5 ml dose is composed of 3 μg of inactivated SARS-CoV-2 virus. The excipients are aluminium hydroxide, disodium hydrogen phosphate, sodium dihydrogen phosphate, sodium chloride, and water for injection.
Study: NCT06117046

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cardiopeptides
Description: Cardiopeptide was administered intravenously once a day with 60mg of cardiopeptide for 3 days
Study: NCT06123065

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Yoga
Description: 8 week Yoga for chronic pain and PTSD group intervention, conducted virtually
Study: NCT04865900

Intervention type: DIAGNOSTIC_TEST
Intervention: Laboratory Blood Tests
Description: Blood tests to determine liver and kidney functioning, total blood count, and troponin levels

Intervention type: DIAGNOSTIC_TEST
Intervention: ECG
Description: ECG to determine heart rate and functioning

Intervention type: DIAGNOSTIC_TEST
Intervention: PCR
Description: PCR test to determine whether patient has Covid19

Intervention type: DIAGNOSTIC_TEST
Intervention: Antibody test
Description: Antibody test to determine level of antibodies to Covid19

Intervention type: DIAGNOSTIC_TEST
Intervention: Echocardiography
Description: If Troponin level elevated echocardiography to determine heart function

Intervention type: DIAGNOSTIC_TEST
Intervention: MRI
Description: If Troponin level elevated MRI to determine heart function
Study: NCT06123065

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Yoga
Description: 8 week Yoga for chronic pain and PTSD group intervention, conducted virtually
Study: NCT04952935

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: True Acupuncture
Description: Delivery of four acupuncture seeds (no needles involved) to the head and neck area at true acupuncture points.

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Sham Acupuncture
Description: Delivery of four acupuncture seeds (no needles involved) to the head and neck area at non-acupuncture points.
Study: NCT05068336

Intervention type: DIAGNOSTIC_TEST
Intervention: desflurane anesthesia
Description: Anesthesia maintenance of the first group will be provided with desflurane, one of the inhalation anesthetics we routinely use. Before and after the operation, blood will be taken from the patients, and the blood will be centrifuged to evaluate the heparan sulfate and syndecan levels.

Intervention type: DIAGNOSTIC_TEST
Intervention: sevoflurane anesthesia
Description: Anesthesia maintenance of the first group will be provided with sevoflurane, one of the inhalation anesthetics we routinely use. Before and after the operation, blood will be taken from the patients, and the blood will be centrifuged to evaluate the heparan sulfate and syndecan levels.
Study: NCT05079945

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Spinal cord Tractography in order to differentiate spinal tracts.
Description: Spinal cord tractography using DTI MRI sequences of the brain and spinal cord, in order to differentiate tracts at the spinal cord level; and by performing a stitching process between Brain and Spinal cord DTI sequences.
Study: NCT06159426

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Vojta Therapy
Description: The subject will be placed on a stretcher with the torso uncovered. Once the adhesive electrodes have been placed in the different recording areas on the anterior part of the trunk, a recording of the activity at rest will begin, two minutes of stimulation (digital pressure), one minute of rest, two minutes of stimulation in the contralateral side and, finally, one minute of rest.~The therapy consists of the application of a stimulating pressure in the pectoral area in the pattern of the locomotion complex of reflex rolling in its first phase. For this, the subject will be placed in a supine position aligned with respect to the axial axis, with the arms along the body, the lower extremities in extension, and the head extended with a rotation of approximately 30º towards one side of the stimulation. The manual stimulation pressure will be exerted in the space between the 6th-7th or the 7th-8th rib under the mammillary line, with a force of about 2 kg.
Study: NCT05303545

Intervention type: OTHER
Intervention: standard of care for patients with poliomyelitis sequelae
Description: clinical examination, radiological, biological and physiological examinations.
Study: NCT06159426

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Vojta Therapy
Description: The subject will be placed on a stretcher with the torso uncovered. Once the adhesive electrodes have been placed in the different recording areas on the anterior part of the trunk, a recording of the activity at rest will begin, two minutes of stimulation (digital pressure), one minute of rest, two minutes of stimulation in the contralateral side and, finally, one minute of rest.~The therapy consists of the application of a stimulating pressure in the pectoral area in the pattern of the locomotion complex of reflex rolling in its first phase. For this, the subject will be placed in a supine position aligned with respect to the axial axis, with the arms along the body, the lower extremities in extension, and the head extended with a rotation of approximately 30º towards one side of the stimulation. The manual stimulation pressure will be exerted in the space between the 6th-7th or the 7th-8th rib under the mammillary line, with a force of about 2 kg.
Study: NCT06171477

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ventilation 20-40-60
Description: The respiratory rate during mechanical ventilation will be altered from 20 to 40 and finally to 60 breaths per minute.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ventilation 60-40-20
Description: The respiratory rate during mechanical ventilation will be altered from 60 to 40 and finally to 20 breaths per minute.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ventilation 40-60-20
Description: The respiratory rate during mechanical ventilation will be altered from 40 to 60 and finally to 20 breaths per minute.
Study: NCT06416579

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Schroth Exercise Group
Description: Exercises will be given in lying, sitting and standing positions. In each exercise, elongation of the spine will be ensured and the person will be positioned according to the type of scoliosis. Exercises will be given progressively in supine, prone, side sitting, sitting and standing positions. In each exercise, elongation of the spine will be ensured and the person will be positioned according to the upper and lower extremities. The exercise program will be divided into 4 phases: 0-4, 5-8, 9-12, 12-24. Progress in the exercises will be made positionally by increasing the number of repetitions and the number of rotational breathing during the exercise.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Schroth Method Based Virtual Reality Group
Description: During Schroth method-based virtual reality exercises, continuity in stabilization will be ensured by using external focus and muscular activation in positions appropriate to the Schroth method and in corrected posture. Sessions will last 40 minutes in total, including 5 minutes of warm-up, 30 minutes of balance and sports games, and 5 minutes of cool-down. Warm-up and cool-down will consist of aerobic games available in Nitendo wii. Balance games will consist of Penguin Slide, Soccer Heading, Table Tilt, Balance Bubble, Ski Slalom, Ski Jump, Tilt City and Snowboard Slalom. Among the sports games, Bowling, Boxing, Tennis and Baseball will be included in the program. Progression will be made by difficulty level and positional in all games. The exercises will be made more difficult by side sitting, side sitting on a stool, sitting position, knight position, standing, sitting on a balance ball, standing on a soft floor, on a bosu ball and moving towards the balance board.
Study: NCT05373927

Intervention type: DEVICE
Intervention: Multispectral Optoacoustic Tomography (MSOT)
Description: Non-invasive transcutaneous imaging of subcellular muscle components via infrared and near-infrared laser pulses
Study: NCT06416579

Intervention type: OTHER
Group type: OTHER
Intervention: Control Group
Description: Participants in the control group will be placed on a waiting list for 24 weeks. Participants will not receive any exercise intervention for 24 weeks and will be able to continue their routine physical activities.